Vilya
@vilyatx.bsky.social
Vilya is a cutting-edge computational biotechnology company, co-founded by a team of scientists from the Institute of Protein Design (IPD) led by David Baker, Ph.D. and ARCH Venture Partners.
Excited to announce Vilya’s exclusive license for RFpeptides, a groundbreaking RFdiffusion-based model for macrocyclic peptide design from the UW Institute for Protein Design and School of Pharmacy! RFpeptides enable de novo design of potent, selective macrocycles to target undruggable proteins.
Vilya Announces Exclusive License Agreement of RFdiffusion-based Generative Model from the University of Washington for the Design of Macrocyclic Peptides
– License of proprietary RFdiffusion-based model, RFpeptides, provides Vilya with another powerful structure prediction framework for rapid and unique...
www.globenewswire.com
November 21, 2024 at 6:43 PM
Excited to announce Vilya’s exclusive license for RFpeptides, a groundbreaking RFdiffusion-based model for macrocyclic peptide design from the UW Institute for Protein Design and School of Pharmacy! RFpeptides enable de novo design of potent, selective macrocycles to target undruggable proteins.
#Vilya is on BlueSky! Follow us for updates on our journey to transform the way #medicines are discovered and developed!
#DrugDiscovery #Macrocycles
#DrugDiscovery #Macrocycles
November 19, 2024 at 11:16 PM
#Vilya is on BlueSky! Follow us for updates on our journey to transform the way #medicines are discovered and developed!
#DrugDiscovery #Macrocycles
#DrugDiscovery #Macrocycles